首页 > 最新文献

世界危重病急救学杂志(英文版)最新文献

英文 中文
Presentation and outcome of myocardial infarction with non-obstructive coronary arteries in coronavirus disease 2019. 2019年冠状病毒病冠状动脉非阻塞性心肌梗死的表现和预后。
Pub Date : 2022-05-09 DOI: 10.5492/wjccm.v11.i3.129
Kevin John, Amos Lal, Nitish Sharma, Amr ElMeligy, Ajay K Mishra

Among the cardiac complications of coronavirus disease 2019 (COVID-19), one increasingly reported in the literature is myocardial infarction with non-obstructive coronaries (MINOCA). We reviewed all reported cases of MINOCA in COVID-19 patients to summarize its clinical features, evaluation, and treatment. We performed a literature search in Pubmed using the search terms 'COVID-19' and 'MINOCA' or 'non-obstructive coronaries'. Among the reported cases, the mean age was 61.5 years (SD ± 13.4), and 50% were men. Chest pain was the presenting symptom in five patients (62.5%), and hypertension was the most common comorbidity (62.5%). ST-elevation was seen in most patients (87.5%), and the overall mortality rate was 37.5%. MINOCA in COVID-19 is an entity with a broad differential diagnosis. Therefore, a uniform algorithm is needed in its evaluation to ensure timely diagnosis and management.

在冠状病毒病 2019(COVID-19)的心脏并发症中,文献中报道较多的一种是冠状动脉非阻塞性心肌梗死(MINOCA)。我们回顾了所有报道的 COVID-19 患者 MINOCA 病例,总结了其临床特征、评估和治疗方法。我们以 "COVID-19 "和 "MINOCA "或 "非阻塞性冠状动脉 "为检索词在 Pubmed 上进行了文献检索。在报告的病例中,平均年龄为 61.5 岁(SD ± 13.4),50% 为男性。胸痛是五名患者(62.5%)的主要症状,高血压是最常见的合并症(62.5%)。大多数患者(87.5%)出现 ST 段抬高,总死亡率为 37.5%。COVID-19中的MINOCA是一种具有广泛鉴别诊断的疾病。因此,需要对其进行统一的评估,以确保及时诊断和处理。
{"title":"Presentation and outcome of myocardial infarction with non-obstructive coronary arteries in coronavirus disease 2019.","authors":"Kevin John, Amos Lal, Nitish Sharma, Amr ElMeligy, Ajay K Mishra","doi":"10.5492/wjccm.v11.i3.129","DOIUrl":"10.5492/wjccm.v11.i3.129","url":null,"abstract":"<p><p>Among the cardiac complications of coronavirus disease 2019 (COVID-19), one increasingly reported in the literature is myocardial infarction with non-obstructive coronaries (MINOCA). We reviewed all reported cases of MINOCA in COVID-19 patients to summarize its clinical features, evaluation, and treatment. We performed a literature search in Pubmed using the search terms 'COVID-19' and 'MINOCA' or 'non-obstructive coronaries'. Among the reported cases, the mean age was 61.5 years (SD ± 13.4), and 50% were men. Chest pain was the presenting symptom in five patients (62.5%), and hypertension was the most common comorbidity (62.5%). ST-elevation was seen in most patients (87.5%), and the overall mortality rate was 37.5%. MINOCA in COVID-19 is an entity with a broad differential diagnosis. Therefore, a uniform algorithm is needed in its evaluation to ensure timely diagnosis and management.</p>","PeriodicalId":66959,"journal":{"name":"世界危重病急救学杂志(英文版)","volume":" ","pages":"129-138"},"PeriodicalIF":0.0,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b5/82/WJCCM-11-129.PMC9136718.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40680835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Critical care practices in the world: Results of the global intensive care unit need assessment survey 2020. 世界重症监护实践:2020 年全球重症监护病房需求评估调查结果》。
Pub Date : 2022-05-09 DOI: 10.5492/wjccm.v11.i3.169
Faisal A Nawaz, Neha Deo, Salim Surani, William Maynard, Martin L Gibbs, Rahul Kashyap

Background: There is variability in intensive care unit (ICU) resources and staffing worldwide. This may reflect variation in practice and outcomes across all health systems.

Aim: To improve research and quality improvement measures administrative leaders can create long-term strategies by understanding the nature of ICU practices on a global scale.

Methods: The Global ICU Needs Assessment Research Group was formed on the basis of diversified skill sets. We aimed to survey sites regarding ICU type, availability of staffing, and adherence to critical care protocols. An international survey 'Global ICU Needs Assessment' was created using Google Forms, and this was distributed from February 17th, 2020 till September 23rd, 2020. The survey was shared with ICU providers in 34 countries. Various approaches to motivating healthcare providers were implemented in securing submissions, including use of emails, phone calls, social media applications, and WhatsApp™. By completing this survey, providers gave their consent for research purposes. This study was deemed eligible for category-2 Institutional Review Board exempt status.

Results: There were a total 121 adult/adult-pediatrics ICU responses from 34 countries in 76 cities. A majority of the ICUs were mixed medical-surgical [92 (76%)]. 108 (89%) were adult-only ICUs. Total 36 respondents (29.8%) were 31-40 years of age, with 79 (65%) male and 41 (35%) female participants. 89 were consultants (74%). A total of 71 (59%) respondents reported having a 24-h in-house intensivist. A total of 87 (72%) ICUs were reported to have either a 2:1 or ≥ 2:1 patient/nurse ratio. About 44% of the ICUs were open and 76% were mixed type (medical-surgical). Protocols followed regularly by the ICUs included sepsis care (82%), ventilator-associated pneumonia (79%); nutrition (76%), deep vein thrombosis prophylaxis (84%), stress ulcer prophylaxis (84%), and glycemic control (89%).

Conclusion: Based on the findings of this international, multi-dimensional, needs-assessment survey, there is a need for increased recruitment and staffing in critical care facilities, along with improved patient-to-nurse ratios. Future research is warranted in this field with focus on implementing appropriate health standards, protocols and resources for optimal efficiency in critical care worldwide.

背景:全球重症监护病房(ICU)的资源和人员配备存在差异。目的:通过了解全球重症监护室的工作性质,行政领导者可以制定长期战略,从而改进研究和质量改进措施:全球重症监护室需求评估研究小组是在多元化技能组合的基础上成立的。我们的目标是调查重症监护室的类型、人员配备情况以及重症监护协议的遵守情况。我们使用谷歌表格创建了 "全球重症监护室需求评估 "国际调查表,并于 2020 年 2 月 17 日至 2020 年 9 月 23 日进行了分发。该调查与 34 个国家的重症监护室提供者分享。在确保提交调查问卷的过程中,我们采用了各种激励医疗服务提供者的方法,包括使用电子邮件、电话、社交媒体应用程序和 WhatsApp™。医疗服务提供者在填写本调查问卷时表示同意将其用于研究目的。这项研究被认为符合机构审查委员会第二类豁免资格:共有来自 34 个国家 76 个城市的 121 个成人/成人-儿科重症监护室回复。大多数重症监护室为内外科混合型[92(76%)]。108所(89%)为成人重症监护病房。共有 36 名受访者(29.8%)的年龄在 31-40 岁之间,其中男性 79 人(65%),女性 41 人(35%)。89 人是顾问(74%)。共有 71 位受访者(59%)表示拥有 24 小时内部重症监护医生。据报告,共有 87 个(72%)重症监护病房的患者/护士比例为 2:1 或≥ 2:1。约 44% 的重症监护室为开放式,76% 为混合型(内外科)。重症监护室定期遵循的协议包括败血症护理(82%)、呼吸机相关肺炎(79%)、营养(76%)、深静脉血栓预防(84%)、应激性溃疡预防(84%)和血糖控制(89%):根据这项国际性、多维度、需求评估调查的结果,重症监护机构需要增加招聘和人员配置,同时改善病人与护士的比例。该领域未来的研究重点是实施适当的健康标准、协议和资源,以在全球范围内实现重症监护的最佳效率。
{"title":"Critical care practices in the world: Results of the global intensive care unit need assessment survey 2020.","authors":"Faisal A Nawaz, Neha Deo, Salim Surani, William Maynard, Martin L Gibbs, Rahul Kashyap","doi":"10.5492/wjccm.v11.i3.169","DOIUrl":"10.5492/wjccm.v11.i3.169","url":null,"abstract":"<p><strong>Background: </strong>There is variability in intensive care unit (ICU) resources and staffing worldwide. This may reflect variation in practice and outcomes across all health systems.</p><p><strong>Aim: </strong>To improve research and quality improvement measures administrative leaders can create long-term strategies by understanding the nature of ICU practices on a global scale.</p><p><strong>Methods: </strong>The Global ICU Needs Assessment Research Group was formed on the basis of diversified skill sets. We aimed to survey sites regarding ICU type, availability of staffing, and adherence to critical care protocols. An international survey 'Global ICU Needs Assessment' was created using Google Forms, and this was distributed from February 17<sup>th</sup>, 2020 till September 23<sup>rd</sup>, 2020. The survey was shared with ICU providers in 34 countries. Various approaches to motivating healthcare providers were implemented in securing submissions, including use of emails, phone calls, social media applications, and WhatsApp™. By completing this survey, providers gave their consent for research purposes. This study was deemed eligible for category-2 Institutional Review Board exempt status.</p><p><strong>Results: </strong>There were a total 121 adult/adult-pediatrics ICU responses from 34 countries in 76 cities. A majority of the ICUs were mixed medical-surgical [92 (76%)]. 108 (89%) were adult-only ICUs. Total 36 respondents (29.8%) were 31-40 years of age, with 79 (65%) male and 41 (35%) female participants. 89 were consultants (74%). A total of 71 (59%) respondents reported having a 24-h in-house intensivist. A total of 87 (72%) ICUs were reported to have either a 2:1 or ≥ 2:1 patient/nurse ratio. About 44% of the ICUs were open and 76% were mixed type (medical-surgical). Protocols followed regularly by the ICUs included sepsis care (82%), ventilator-associated pneumonia (79%); nutrition (76%), deep vein thrombosis prophylaxis (84%), stress ulcer prophylaxis (84%), and glycemic control (89%).</p><p><strong>Conclusion: </strong>Based on the findings of this international, multi-dimensional, needs-assessment survey, there is a need for increased recruitment and staffing in critical care facilities, along with improved patient-to-nurse ratios. Future research is warranted in this field with focus on implementing appropriate health standards, protocols and resources for optimal efficiency in critical care worldwide.</p>","PeriodicalId":66959,"journal":{"name":"世界危重病急救学杂志(英文版)","volume":" ","pages":"169-177"},"PeriodicalIF":0.0,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9a/49/WJCCM-11-169.PMC9136725.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40665942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diuretic combinations in critically ill patients with respiratory failure: A systematic review and meta-analysis. 利尿剂联合治疗危重患者呼吸衰竭:系统回顾和荟萃分析。
Pub Date : 2022-05-09 DOI: 10.5492/wjccm.v11.i3.178
Jean Maxime Côté, Nadir Goulamhoussen, Blaithin A McMahon, Patrick T Murray

Background: In patients with respiratory failure, loop diuretics remain the cornerstone of the treatment to maintain fluid balance, but resistance is common.

Aim: To determine the efficacy and safety of common diuretic combinations in critically ill patients with respiratory failure.

Methods: We searched MEDLINE, Embase, Cochrane Library and PROSPERO for studies reporting the effects of a combination of a loop diuretic with another class of diuretic. A meta-analysis using mean differences (MD) with 95% confidence interval (CI) was performed for the 24-h fluid balance (primary outcome) and the 24-h urine output, while descriptive statistics were used for safety events.

Results: Nine studies totalling 440 patients from a total of 6510 citations were included. When compared to loop diuretics alone, the addition of a second diuretic is associated with an improved negative fluid balance at 24 h [MD: -1.06 L (95%CI: -1.46; -0.65)], driven by the combination of a thiazide plus furosemide [MD: -1.25 L (95%CI: -1.68; -0.82)], while no difference was observed with the combination of a loop-diuretic plus acetazolamide [MD: -0.40 L (95%CI: -0.96; 0.16)] or spironolactone [MD: -0.65 L (95%CI: -1.66; 0.36)]. Heterogeneity was high and the report of clinical and safety endpoints varied across studies.

Conclusion: Based on limited evidence, the addition of a second diuretic to a loop diuretic may promote diuresis and negative fluid balance in patients with respiratory failure, but only when using a thiazide. Further larger trials to evaluate the safety and efficacy of such interventions in patients with respiratory failure are required.

背景:在呼吸衰竭患者中,循环利尿剂仍然是维持体液平衡治疗的基础,但抵抗是常见的。目的:探讨常用利尿剂联合应用对危重呼吸衰竭患者的疗效和安全性。方法:我们检索了MEDLINE、Embase、Cochrane Library和PROSPERO,以报告一种环状利尿剂与另一种利尿剂联合使用的效果。采用95%可信区间(CI)的平均差异(MD)对24小时体液平衡(主要结局)和24小时尿量进行meta分析,同时对安全事件进行描述性统计。结果:纳入9项研究,共计440例患者,共6510次引用。与单独使用环状利尿剂相比,添加第二种利尿剂可改善24 h时的负体液平衡[MD: -1.06 L (95%CI: -1.46;-0.65)],由噻嗪类药物联合呋塞米驱动[MD: -1.25 L (95%CI: -1.68;-0.82)],而环利尿剂联合乙酰唑胺组无差异[MD: -0.40 L (95%CI: -0.96;0.16)]或螺内酯[MD: -0.65 L (95%CI: -1.66;0.36)]。异质性很高,临床和安全性终点的报告在不同的研究中有所不同。结论:基于有限的证据,在循环利尿剂的基础上添加第二种利尿剂可能促进呼吸衰竭患者的利尿和负体液平衡,但仅当使用噻嗪类药物时。需要进一步进行更大规模的试验来评估这些干预措施对呼吸衰竭患者的安全性和有效性。
{"title":"Diuretic combinations in critically ill patients with respiratory failure: A systematic review and meta-analysis.","authors":"Jean Maxime Côté,&nbsp;Nadir Goulamhoussen,&nbsp;Blaithin A McMahon,&nbsp;Patrick T Murray","doi":"10.5492/wjccm.v11.i3.178","DOIUrl":"https://doi.org/10.5492/wjccm.v11.i3.178","url":null,"abstract":"<p><strong>Background: </strong>In patients with respiratory failure, loop diuretics remain the cornerstone of the treatment to maintain fluid balance, but resistance is common.</p><p><strong>Aim: </strong>To determine the efficacy and safety of common diuretic combinations in critically ill patients with respiratory failure.</p><p><strong>Methods: </strong>We searched MEDLINE, Embase, Cochrane Library and PROSPERO for studies reporting the effects of a combination of a loop diuretic with another class of diuretic. A meta-analysis using mean differences (MD) with 95% confidence interval (CI) was performed for the 24-h fluid balance (primary outcome) and the 24-h urine output, while descriptive statistics were used for safety events.</p><p><strong>Results: </strong>Nine studies totalling 440 patients from a total of 6510 citations were included. When compared to loop diuretics alone, the addition of a second diuretic is associated with an improved negative fluid balance at 24 h [MD: -1.06 L (95%CI: -1.46; -0.65)], driven by the combination of a thiazide plus furosemide [MD: -1.25 L (95%CI: -1.68; -0.82)], while no difference was observed with the combination of a loop-diuretic plus acetazolamide [MD: -0.40 L (95%CI: -0.96; 0.16)] or spironolactone [MD: -0.65 L (95%CI: -1.66; 0.36)]. Heterogeneity was high and the report of clinical and safety endpoints varied across studies.</p><p><strong>Conclusion: </strong>Based on limited evidence, the addition of a second diuretic to a loop diuretic may promote diuresis and negative fluid balance in patients with respiratory failure, but only when using a thiazide. Further larger trials to evaluate the safety and efficacy of such interventions in patients with respiratory failure are required.</p>","PeriodicalId":66959,"journal":{"name":"世界危重病急救学杂志(英文版)","volume":" ","pages":"178-191"},"PeriodicalIF":0.0,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/20/80/WJCCM-11-178.PMC9136719.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40665002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Stress cardiomyopathy in critical care: A case series of 109 patients. 重症监护中的应激性心肌病:109例患者的病例系列。
Pub Date : 2022-05-09 DOI: 10.5492/wjccm.v11.i3.149
Parth Pancholi, Nader Emami, Melissa J Fazzari, Sumit Kapoor

Background: Critically ill patients are at risk of developing stress cardiomyopathy (SC) but can be under-recognized.

Aim: To describe a case series of patients with SC admitted to critical care units.

Methods: We conducted a retrospective observational study at a tertiary care teaching hospital. All adult (≥ 18 years old) patients admitted to the critical care units with stress cardiomyopathy over 5 years were included.

Results: Of 24279 admissions to the critical care units [19139 to medical-surgical intensive care units (MSICUs) and 5140 in coronary care units (CCUs)], 109 patients with SC were identified. Sixty (55%) were admitted to the coronary care units (CCUs) and forty-nine (45%) to the medical-surgical units (MSICUs). The overall incidence of SC was 0.44%, incidence in CCU and MSICU was 1.16% and 0.25% respectively. Sixty-two (57%) had confirmed SC and underwent cardiac catheterization whereas 47 (43%) had clinical SC, and did not undergo cardiac catheterization. Forty-three (72%) patients in the CCUs were diagnosed with primary SC, whereas all (100%) patients in MSICUs developed secondary SC. Acute respiratory failure that required invasive mechanical ventilation and shock developed in twenty-nine (59%) MSICU patients. There were no statistically significant differences in intensive care unit (ICU) mortality, in-hospital mortality, use of inotropic or mechanical circulatory support based on type of unit or anatomical variant.

Conclusion: Stress cardiomyopathy can be under-recognized in the critical care setting. Intensivists should have a high index of suspicion for SC in patients who develop sudden or worsening unexplained hemodynamic instability, arrhythmias or respiratory failure in ICU.

背景:危重患者有发生应激性心肌病(SC)的风险,但可能未被充分认识。目的:描述一系列入住重症监护病房的SC患者的病例。方法:在某三级教学医院进行回顾性观察研究。所有5年以上因应激性心肌病入住重症监护病房的成人(≥18岁)患者均被纳入研究。结果:在24279例重症监护病房(19139例内科外科重症监护病房(MSICUs)和5140例冠状动脉监护病房(CCUs))入院的患者中,109例确诊为SC。60例(55%)入住冠状动脉监护病房(CCUs), 49例(45%)入住内科外科病房(msicu)。SC的总发病率为0.44%,CCU和MSICU的发病率分别为1.16%和0.25%。62例(57%)确诊为SC并接受了心导管插入术,而47例(43%)有临床SC,未接受心导管插入术。43例(72%)ccu患者被诊断为原发性SC,而所有(100%)MSICU患者被诊断为继发性SC。29例(59%)MSICU患者出现急性呼吸衰竭,需要有创机械通气和休克。重症监护病房(ICU)死亡率、住院死亡率、肌力或机械循环支持的使用在单位类型或解剖变异上无统计学显著差异。结论:应激性心肌病在重症监护中可能被低估。重症监护医师应高度怀疑ICU中出现突然或恶化的不明原因血流动力学不稳定、心律失常或呼吸衰竭的SC患者。
{"title":"Stress cardiomyopathy in critical care: A case series of 109 patients.","authors":"Parth Pancholi,&nbsp;Nader Emami,&nbsp;Melissa J Fazzari,&nbsp;Sumit Kapoor","doi":"10.5492/wjccm.v11.i3.149","DOIUrl":"https://doi.org/10.5492/wjccm.v11.i3.149","url":null,"abstract":"<p><strong>Background: </strong>Critically ill patients are at risk of developing stress cardiomyopathy (SC) but can be under-recognized.</p><p><strong>Aim: </strong>To describe a case series of patients with SC admitted to critical care units.</p><p><strong>Methods: </strong>We conducted a retrospective observational study at a tertiary care teaching hospital. All adult (≥ 18 years old) patients admitted to the critical care units with stress cardiomyopathy over 5 years were included.</p><p><strong>Results: </strong>Of 24279 admissions to the critical care units [19139 to medical-surgical intensive care units (MSICUs) and 5140 in coronary care units (CCUs)], 109 patients with SC were identified. Sixty (55%) were admitted to the coronary care units (CCUs) and forty-nine (45%) to the medical-surgical units (MSICUs). The overall incidence of SC was 0.44%, incidence in CCU and MSICU was 1.16% and 0.25% respectively. Sixty-two (57%) had confirmed SC and underwent cardiac catheterization whereas 47 (43%) had clinical SC, and did not undergo cardiac catheterization. Forty-three (72%) patients in the CCUs were diagnosed with primary SC, whereas all (100%) patients in MSICUs developed secondary SC. Acute respiratory failure that required invasive mechanical ventilation and shock developed in twenty-nine (59%) MSICU patients. There were no statistically significant differences in intensive care unit (ICU) mortality, in-hospital mortality, use of inotropic or mechanical circulatory support based on type of unit or anatomical variant.</p><p><strong>Conclusion: </strong>Stress cardiomyopathy can be under-recognized in the critical care setting. Intensivists should have a high index of suspicion for SC in patients who develop sudden or worsening unexplained hemodynamic instability, arrhythmias or respiratory failure in ICU.</p>","PeriodicalId":66959,"journal":{"name":"世界危重病急救学杂志(英文版)","volume":" ","pages":"149-159"},"PeriodicalIF":0.0,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/79/3c/WJCCM-11-149.PMC9136722.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40665943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Need for oxygen therapy and ventilatory support in premature infants in a hospital in Southern Brazil. 巴西南部一家医院早产儿的氧气治疗和呼吸支持需求。
Pub Date : 2022-05-09 DOI: 10.5492/wjccm.v11.i3.160
Amanda Meier, Kelser de Souza Kock

Background: Prematurity in newborns is a condition that is associated with worse hospital outcomes when compared to birth to term. A preterm infant (PI) is classified when gestational age (GA) < 37 wk.

Aim: To analyze prognostic indicators related to the use of oxygen therapy, non-invasive ventilation (continuous positive airway pressure) and mechanical ventilation (MV) in PI.

Methods: This is a retrospective cohort. The sample was composed of PIs from a private hospital in southern Brazil. We included neonates with GA < 37 wk of gestation in the period of January 1, 2018 to December 31, 2018. For data collection, electronic records were used in the Tasy PhilipsTM system, identifying the variables: maternal age, type of birth, prenatal information, GA, Apgar score, birth weight, neonatal morbidities, vital signs in the 1st hour at birth, need for oxygen therapy, continuous positive airway pressure and MV, hospitalization in the neonatal intensive care unit, length of stay and discharge or death.

Results: In total, 90 PI records were analyzed. The median (p25-p75) of GA was 34.0 (31.9-35.4) wk, and there were 45 (50%) males. The most common morbidity among PIs was the acute respiratory discomfort syndrome, requiring hospitalization in the neonatal intensive care unit in 76 (84.4%) cases. The utilization rate of oxygen therapy, continuous positive airway pressure and MV was 12 (13.3%), 37 (41.1%) and 13 (14.4%), respectively. The median (p25-p75) length of stay was 12.0 (5.0-22.2) d, with 10 (11.1%) deaths. A statistical association was observed with the use of MV and GA < 28 wk, lower maternal age, low birth weight, Apgar < 8 and neonatal deaths.

Conclusion: The identification of factors related to the need for MV in prematurity may help in the indication of a qualified team and technologies to promptly meet the unforeseen events that may occur after birth.

背景:与足月儿相比,早产儿的住院预后较差。目的:分析与早产儿使用氧疗、无创通气(持续气道正压)和机械通气(MV)有关的预后指标:这是一项回顾性队列研究。样本由巴西南部一家私立医院的 PI 组成。我们纳入了 2018 年 1 月 1 日至 2018 年 12 月 31 日期间妊娠期 GA 小于 37 周的新生儿。数据收集使用了 Tasy PhilipsTM 系统中的电子记录,确定了以下变量:产妇年龄、分娩类型、产前信息、GA、Apgar 评分、出生体重、新生儿发病率、出生后 1 小时内的生命体征、氧疗需求、持续气道正压和 MV、新生儿重症监护室住院情况、住院时间和出院或死亡:共分析了 90 份 PI 记录。GA的中位数(p25-p75)为34.0(31.9-35.4)周,男性有45人(50%)。新生儿感染中最常见的发病是急性呼吸道不适综合征,76 例(84.4%)需要在新生儿重症监护室住院治疗。氧疗、持续气道正压和 MV 的使用率分别为 12(13.3%)、37(41.1%)和 13(14.4%)。住院时间中位数(p25-p75)为 12.0(5.0-22.2)天,死亡人数为 10(11.1%)人。观察到使用中压和孕期小于28周、产妇年龄较小、出生体重较低、Apgar小于8和新生儿死亡之间存在统计学关联:结论:确定早产儿是否需要使用中压的相关因素,有助于确定合格的团队和技术,及时应对出生后可能发生的意外情况。
{"title":"Need for oxygen therapy and ventilatory support in premature infants in a hospital in Southern Brazil.","authors":"Amanda Meier, Kelser de Souza Kock","doi":"10.5492/wjccm.v11.i3.160","DOIUrl":"10.5492/wjccm.v11.i3.160","url":null,"abstract":"<p><strong>Background: </strong>Prematurity in newborns is a condition that is associated with worse hospital outcomes when compared to birth to term. A preterm infant (PI) is classified when gestational age (GA) < 37 wk.</p><p><strong>Aim: </strong>To analyze prognostic indicators related to the use of oxygen therapy, non-invasive ventilation (continuous positive airway pressure) and mechanical ventilation (MV) in PI.</p><p><strong>Methods: </strong>This is a retrospective cohort. The sample was composed of PIs from a private hospital in southern Brazil. We included neonates with GA < 37 wk of gestation in the period of January 1, 2018 to December 31, 2018. For data collection, electronic records were used in the Tasy Philips<sup>TM</sup> system, identifying the variables: maternal age, type of birth, prenatal information, GA, Apgar score, birth weight, neonatal morbidities, vital signs in the 1st hour at birth, need for oxygen therapy, continuous positive airway pressure and MV, hospitalization in the neonatal intensive care unit, length of stay and discharge or death.</p><p><strong>Results: </strong>In total, 90 PI records were analyzed. The median (p25-p75) of GA was 34.0 (31.9-35.4) wk, and there were 45 (50%) males. The most common morbidity among PIs was the acute respiratory discomfort syndrome, requiring hospitalization in the neonatal intensive care unit in 76 (84.4%) cases. The utilization rate of oxygen therapy, continuous positive airway pressure and MV was 12 (13.3%), 37 (41.1%) and 13 (14.4%), respectively. The median (p25-p75) length of stay was 12.0 (5.0-22.2) d, with 10 (11.1%) deaths. A statistical association was observed with the use of MV and GA < 28 wk, lower maternal age, low birth weight, Apgar < 8 and neonatal deaths.</p><p><strong>Conclusion: </strong>The identification of factors related to the need for MV in prematurity may help in the indication of a qualified team and technologies to promptly meet the unforeseen events that may occur after birth.</p>","PeriodicalId":66959,"journal":{"name":"世界危重病急救学杂志(英文版)","volume":" ","pages":"160-168"},"PeriodicalIF":0.0,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b3/1c/WJCCM-11-160.PMC9136723.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40680834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ideal scoring system for acute pancreatitis: Quest for the Holy Grail. 理想的急性胰腺炎评分系统:追求圣杯。
Pub Date : 2022-05-09 DOI: 10.5492/wjccm.v11.i3.198
Deven Juneja

Clinical scoring systems are required to predict complications, severity, need for intensive care unit admission, and mortality in patients with acute pancreatitis. Over the years, many scores have been developed, tested, and compared for their efficacy and accuracy. An ideal score should be rapid, reliable, and validated in different patient populations and geographical areas and should not lose relevance over time. A combination of scores or serial monitoring of a single score may increase their efficacy.

需要临床评分系统来预测急性胰腺炎患者的并发症、严重程度、重症监护病房入院需求和死亡率。多年来,人们开发、测试和比较了许多分数的有效性和准确性。理想的评分应该是快速、可靠的,并在不同的患者群体和地理区域中得到验证,并且不应该随着时间的推移而失去相关性。分数的组合或单个分数的连续监测可能会提高它们的功效。
{"title":"Ideal scoring system for acute pancreatitis: Quest for the Holy Grail.","authors":"Deven Juneja","doi":"10.5492/wjccm.v11.i3.198","DOIUrl":"https://doi.org/10.5492/wjccm.v11.i3.198","url":null,"abstract":"<p><p>Clinical scoring systems are required to predict complications, severity, need for intensive care unit admission, and mortality in patients with acute pancreatitis. Over the years, many scores have been developed, tested, and compared for their efficacy and accuracy. An ideal score should be rapid, reliable, and validated in different patient populations and geographical areas and should not lose relevance over time. A combination of scores or serial monitoring of a single score may increase their efficacy.</p>","PeriodicalId":66959,"journal":{"name":"世界危重病急救学杂志(英文版)","volume":" ","pages":"198-200"},"PeriodicalIF":0.0,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7a/d7/WJCCM-11-198.PMC9136720.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40665910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Plasma D-dimer level in early and late-onset neonatal sepsis. 血浆d -二聚体水平与早、晚发型新生儿败血症的关系。
Pub Date : 2022-05-09 DOI: 10.5492/wjccm.v11.i3.139
Mohammed Al-Biltagi, Ehab M Hantash, Mohammed Ramadan El-Shanshory, Enayat Aly Badr, Mohamed Zahra, Manar Hany Anwar

Background: Neonatal sepsis is a life-threatening disease. Early diagnosis is essential, but no single marker of infection has been identified. Sepsis activates a coagulation cascade with simultaneous production of the D-dimers due to lysis of fibrin. D-dimer test reflects the activation of the coagulation system.

Aim: To assess the D-dimer plasma level, elaborating its clinicopathological value in neonates with early-onset and late-onset neonatal sepsis.

Methods: The study was a prospective cross-sectional study that included ninety neonates; divided into three groups: Group I: Early-onset sepsis (EOS); Group II: Late-onset sepsis (LOS); and Group III: Control group. We diagnosed neonatal sepsis according to our protocol. C-reactive protein (CRP) and D-dimer assays were compared between EOS and LOS and correlated to the causative microbiological agents.

Results: D-dimer was significantly higher in septic groups with a considerably higher number of cases with positive D-dimer. Neonates with LOS had substantially higher levels of D-dimer than EOS, with no significant differences in CRP. Neonates with LOS had a significantly longer hospitalization duration and higher gram-negative bacteriemia and mortality rates than EOS (P < 0.01). Gram-negative bacteria have the highest D-dimer levels (Acinetobacter, Klebsiella, and Pseudomonas) and CRP (Serratia, Klebsiella, and Pseudomonas); while gram-positive sepsis was associated with relatively lower levels. D-dimer had a significant negative correlation with hemoglobin level and platelet count; and a significant positive correlation with CRP, hospitalization duration, and mortality rates. The best-suggested cut-off point for D-dimer in neonatal sepsis was 0.75 mg/L, giving a sensitivity of 72.7% and specificity of 86.7%. The D-dimer assay has specificity and sensitivity comparable to CRP in the current study.

Conclusion: The current study revealed a significant diagnostic value for D-dimer in neonatal sepsis. D-dimer can be used as an adjunct to other sepsis markers to increase the sensitivity and specificity of diagnosing neonatal sepsis.

背景:新生儿败血症是一种危及生命的疾病。早期诊断至关重要,但尚未发现单一的感染标志。脓毒症激活凝血级联反应,同时由于纤维蛋白的裂解产生d -二聚体。d -二聚体试验反映凝血系统的激活。目的:探讨d -二聚体在新生儿早、晚发型脓毒症中的临床病理意义。方法:本研究为前瞻性横断面研究,纳入90例新生儿;分为三组:第一组:早发性脓毒症(EOS);第二组:迟发性脓毒症(LOS);第三组:对照组。我们根据方案诊断新生儿败血症。c -反应蛋白(CRP)和d -二聚体测定在EOS和LOS之间进行比较,并与致病微生物因子相关。结果:脓毒症组d -二聚体明显增高,且d -二聚体阳性的病例数明显增多。LOS新生儿的d -二聚体水平明显高于EOS, CRP水平无显著差异。LOS患儿住院时间、革兰氏阴性菌血症和死亡率均显著高于EOS患儿(P < 0.01)。革兰氏阴性菌具有最高的d -二聚体水平(不动杆菌、克雷伯氏菌和假单胞菌)和CRP(沙雷氏菌、克雷伯氏菌和假单胞菌);而革兰氏阳性败血症则与相对较低的水平相关。d -二聚体与血红蛋白水平、血小板计数呈显著负相关;与CRP、住院时间、死亡率呈显著正相关。d -二聚体诊断新生儿脓毒症的最佳临界值为0.75 mg/L,敏感性为72.7%,特异性为86.7%。在目前的研究中,d -二聚体检测具有与CRP相当的特异性和敏感性。结论:本研究揭示了d -二聚体在新生儿败血症诊断中的重要价值。d -二聚体可作为其他脓毒症标志物的辅助,提高诊断新生儿脓毒症的敏感性和特异性。
{"title":"Plasma D-dimer level in early and late-onset neonatal sepsis.","authors":"Mohammed Al-Biltagi,&nbsp;Ehab M Hantash,&nbsp;Mohammed Ramadan El-Shanshory,&nbsp;Enayat Aly Badr,&nbsp;Mohamed Zahra,&nbsp;Manar Hany Anwar","doi":"10.5492/wjccm.v11.i3.139","DOIUrl":"https://doi.org/10.5492/wjccm.v11.i3.139","url":null,"abstract":"<p><strong>Background: </strong>Neonatal sepsis is a life-threatening disease. Early diagnosis is essential, but no single marker of infection has been identified. Sepsis activates a coagulation cascade with simultaneous production of the D-dimers due to lysis of fibrin. D-dimer test reflects the activation of the coagulation system.</p><p><strong>Aim: </strong>To assess the D-dimer plasma level, elaborating its clinicopathological value in neonates with early-onset and late-onset neonatal sepsis.</p><p><strong>Methods: </strong>The study was a prospective cross-sectional study that included ninety neonates; divided into three groups: Group I: Early-onset sepsis (EOS); Group II: Late-onset sepsis (LOS); and Group III: Control group. We diagnosed neonatal sepsis according to our protocol. C-reactive protein (CRP) and D-dimer assays were compared between EOS and LOS and correlated to the causative microbiological agents.</p><p><strong>Results: </strong>D-dimer was significantly higher in septic groups with a considerably higher number of cases with positive D-dimer. Neonates with LOS had substantially higher levels of D-dimer than EOS, with no significant differences in CRP. Neonates with LOS had a significantly longer hospitalization duration and higher gram-negative bacteriemia and mortality rates than EOS (<i>P</i> < 0.01). Gram-negative bacteria have the highest D-dimer levels (Acinetobacter, Klebsiella, and Pseudomonas) and CRP (Serratia, Klebsiella, and Pseudomonas); while gram-positive sepsis was associated with relatively lower levels. D-dimer had a significant negative correlation with hemoglobin level and platelet count; and a significant positive correlation with CRP, hospitalization duration, and mortality rates. The best-suggested cut-off point for D-dimer in neonatal sepsis was 0.75 mg/L, giving a sensitivity of 72.7% and specificity of 86.7%. The D-dimer assay has specificity and sensitivity comparable to CRP in the current study.</p><p><strong>Conclusion: </strong>The current study revealed a significant diagnostic value for D-dimer in neonatal sepsis. D-dimer can be used as an adjunct to other sepsis markers to increase the sensitivity and specificity of diagnosing neonatal sepsis.</p>","PeriodicalId":66959,"journal":{"name":"世界危重病急救学杂志(英文版)","volume":" ","pages":"139-148"},"PeriodicalIF":0.0,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f7/c6/WJCCM-11-139.PMC9136721.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40665913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Association of latitude and altitude with adverse outcomes in patients with COVID-19: The VIRUS registry. 纬度和海拔与COVID-19患者不良后果的关系:病毒登记
Pub Date : 2022-03-09 DOI: 10.5492/wjccm.v11.i2.102
Aysun Tekin, Shahraz Qamar, Romil Singh, Vikas Bansal, Mayank Sharma, Allison M LeMahieu, Andrew C Hanson, Phillip J Schulte, Marija Bogojevic, Neha Deo, Simon Zec, Diana J Valencia Morales, Katherine A Belden, Smith F Heavner, Margit Kaufman, Sreekanth Cheruku, Valerie C Danesh, Valerie M Banner-Goodspeed, Catherine A St Hill, Amy B Christie, Syed A Khan, Lynn Retford, Karen Boman, Vishakha K Kumar, John C O'Horo, Juan Pablo Domecq, Allan J Walkey, Ognjen Gajic, Rahul Kashyap, Salim Surani

Background: The coronavirus disease 2019 (COVID-19) course may be affected by environmental factors. Ecological studies previously suggested a link between climatological factors and COVID-19 fatality rates. However, individual-level impact of these factors has not been thoroughly evaluated yet.

Aim: To study the association of climatological factors related to patient location with unfavorable outcomes in patients.

Methods: In this observational analysis of the Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study: COVID-19 Registry cohort, the latitudes and altitudes of hospitals were examined as a covariate for mortality within 28 d of admission and the length of hospital stay. Adjusting for baseline parameters and admission date, multivariable regression modeling was utilized. Generalized estimating equations were used to fit the models.

Results: Twenty-two thousand one hundred eight patients from over 20 countries were evaluated. The median age was 62 (interquartile range: 49-74) years, and 54% of the included patients were males. The median age increased with increasing latitude as well as the frequency of comorbidities. Contrarily, the percentage of comorbidities was lower in elevated altitudes. Mortality within 28 d of hospital admission was found to be 25%. The median hospital-free days among all included patients was 20 d. Despite the significant linear relationship between mortality and hospital-free days (adjusted odds ratio (aOR) = 1.39 (1.04, 1.86), P = 0.025 for mortality within 28 d of admission; aOR = -1.47 (-2.60, -0.33), P = 0.011 for hospital-free days), suggesting that adverse patient outcomes were more common in locations further away from the Equator; the results were no longer significant when adjusted for baseline differences (aOR = 1.32 (1.00, 1.74), P = 0.051 for 28-day mortality; aOR = -1.07 (-2.13, -0.01), P = 0.050 for hospital-free days). When we looked at the altitude's effect, we discovered that it demonstrated a non-linear association with mortality within 28 d of hospital admission (aOR = 0.96 (0.62, 1.47), 1.04 (0.92, 1.19), 0.49 (0.22, 0.90), and 0.51 (0.27, 0.98), for the altitude points of 75 MASL, 125 MASL, 400 MASL, and 600 MASL, in comparison to the reference altitude of 148 m.a.s.l, respectively. P = 0.001). We detected an association between latitude and 28-day mortality as well as hospital-free days in this worldwide study. When the baseline features were taken into account, however, this did not stay significant.

Conclusion: Our findings suggest that differences observed in previous epidemiological studies may be due to ecological fallacy rather than implying a causal relationship at the patient level.

背景2019冠状病毒病(新冠肺炎)病程可能受到环境因素的影响。生态研究先前表明气候因素与新冠肺炎死亡率之间存在联系。然而,这些因素在个体层面的影响还没有得到彻底的评估。目的研究与患者位置相关的气候因素与患者不良预后的关系。方法在这项对重症监护医学会发现病毒感染和呼吸系统疾病通用研究新冠肺炎登记队列的观察性分析中,医院的纬度和海拔被检查为入院28天内死亡率和住院时间的协变量。调整基线参数和入院日期后,采用多变量回归模型。采用广义估计方程对模型进行拟合。结果对来自20多个国家的28名患者进行了评估。中位年龄为62岁(四分位间距:49-74),54%的纳入患者为男性。中位年龄随着纬度和合并症频率的增加而增加。相反,在高海拔地区,合并症的百分比较低。入院后28天内的死亡率为25%。所有纳入患者的平均无住院天数为20天。尽管死亡率和无住院天数之间存在显著的线性关系(调整后的比值比(aOR)=1.39(1.04,1.86),但入院28天内的死亡率P=0.025;aOR=-1.47(-2.60,-0.33),无住院天数P=0.011),表明患者的不良后果在远离赤道的地区更为常见;当校正基线差异时,结果不再显著(aOR=1.32(1.00,1.74),28天死亡率P=0.051;aOR=1.07(-2.13,-0.01),无住院天数P=0.050)。当我们观察海拔高度的影响时,我们发现,与148 m.a.s.l的参考海拔相比,75 MASL、125 MASL、400 MASL和600 MASL的海拔点与入院28天内的死亡率呈非线性关系(aOR=0.96(0.62,1.47)、1.04(0.92,1.19)、0.49(0.22,0.90)和0.51(0.27,0.98)。P=0.001)。在这项全球研究中,我们发现纬度与28天死亡率以及无住院天数之间存在关联。然而,当考虑到基线特征时,这并没有保持显著性。结论我们的研究结果表明,在以前的流行病学研究中观察到的差异可能是由于生态谬误,而不是暗示患者层面的因果关系。
{"title":"Association of latitude and altitude with adverse outcomes in patients with COVID-19: The VIRUS registry.","authors":"Aysun Tekin, Shahraz Qamar, Romil Singh, Vikas Bansal, Mayank Sharma, Allison M LeMahieu, Andrew C Hanson, Phillip J Schulte, Marija Bogojevic, Neha Deo, Simon Zec, Diana J Valencia Morales, Katherine A Belden, Smith F Heavner, Margit Kaufman, Sreekanth Cheruku, Valerie C Danesh, Valerie M Banner-Goodspeed, Catherine A St Hill, Amy B Christie, Syed A Khan, Lynn Retford, Karen Boman, Vishakha K Kumar, John C O'Horo, Juan Pablo Domecq, Allan J Walkey, Ognjen Gajic, Rahul Kashyap, Salim Surani","doi":"10.5492/wjccm.v11.i2.102","DOIUrl":"10.5492/wjccm.v11.i2.102","url":null,"abstract":"<p><strong>Background: </strong>The coronavirus disease 2019 (COVID-19) course may be affected by environmental factors. Ecological studies previously suggested a link between climatological factors and COVID-19 fatality rates. However, individual-level impact of these factors has not been thoroughly evaluated yet.</p><p><strong>Aim: </strong>To study the association of climatological factors related to patient location with unfavorable outcomes in patients.</p><p><strong>Methods: </strong>In this observational analysis of the Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study: COVID-19 Registry cohort, the latitudes and altitudes of hospitals were examined as a covariate for mortality within 28 d of admission and the length of hospital stay. Adjusting for baseline parameters and admission date, multivariable regression modeling was utilized. Generalized estimating equations were used to fit the models.</p><p><strong>Results: </strong>Twenty-two thousand one hundred eight patients from over 20 countries were evaluated. The median age was 62 (interquartile range: 49-74) years, and 54% of the included patients were males. The median age increased with increasing latitude as well as the frequency of comorbidities. Contrarily, the percentage of comorbidities was lower in elevated altitudes. Mortality within 28 d of hospital admission was found to be 25%. The median hospital-free days among all included patients was 20 d. Despite the significant linear relationship between mortality and hospital-free days (adjusted odds ratio (aOR) = 1.39 (1.04, 1.86), <i>P =</i> 0.025 for mortality within 28 d of admission; aOR = -1.47 (-2.60, -0.33), <i>P =</i> 0.011 for hospital-free days), suggesting that adverse patient outcomes were more common in locations further away from the Equator; the results were no longer significant when adjusted for baseline differences (aOR = 1.32 (1.00, 1.74), <i>P</i> = 0.051 for 28-day mortality; aOR = -1.07 (-2.13, -0.01), <i>P =</i> 0.050 for hospital-free days). When we looked at the altitude's effect, we discovered that it demonstrated a non-linear association with mortality within 28 d of hospital admission (aOR = 0.96 (0.62, 1.47), 1.04 (0.92, 1.19), 0.49 (0.22, 0.90), and 0.51 (0.27, 0.98), for the altitude points of 75 MASL, 125 MASL, 400 MASL, and 600 MASL, in comparison to the reference altitude of 148 m.a.s.l, respectively. <i>P =</i> 0.001). We detected an association between latitude and 28-day mortality as well as hospital-free days in this worldwide study. When the baseline features were taken into account, however, this did not stay significant.</p><p><strong>Conclusion: </strong>Our findings suggest that differences observed in previous epidemiological studies may be due to ecological fallacy rather than implying a causal relationship at the patient level.</p>","PeriodicalId":66959,"journal":{"name":"世界危重病急救学杂志(英文版)","volume":"11 1","pages":"102-111"},"PeriodicalIF":0.0,"publicationDate":"2022-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968480/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43624753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Precision medicine in sepsis and septic shock: From omics to clinical tools. 败血症和感染性休克的精准医学:从组学到临床工具
Pub Date : 2022-01-09 DOI: 10.5492/wjccm.v11.i1.1
Juan Carlos Ruiz-Rodriguez, Erika P Plata-Menchaca, Luis Chiscano-Camón, Adolfo Ruiz-Sanmartin, Marcos Pérez-Carrasco, Clara Palmada, Vicent Ribas, Mónica Martínez-Gallo, Manuel Hernández-González, Juan J Gonzalez-Lopez, Nieves Larrosa, Ricard Ferrer

Sepsis is a heterogeneous disease with variable clinical course and several clinical phenotypes. As it is associated with an increased risk of death, patients with this condition are candidates for receipt of a very well-structured and protocolized treatment. All patients should receive the fundamental pillars of sepsis management, which are infection control, initial resuscitation, and multiorgan support. However, specific subgroups of patients may benefit from a personalized approach with interventions targeted towards specific pathophysiological mechanisms. Herein, we will review the framework for identifying subpopulations of patients with sepsis, septic shock, and multiorgan dysfunction who may benefit from specific therapies. Some of these approaches are still in the early stages of research, while others are already in routine use in clinical practice, but together will help in the effective generation and safe implementation of precision medicine in sepsis.

脓毒症是一种异质性疾病,具有不同的临床病程和多种临床表型。由于它与死亡风险增加有关,患有这种疾病的患者是接受结构良好和有方案的治疗的候选者。所有患者都应接受脓毒症治疗的基本支柱,即感染控制、初始复苏和多器官支持。然而,特定的亚组患者可能受益于针对特定病理生理机制的个性化干预方法。在此,我们将回顾识别可能受益于特定治疗的败血症、感染性休克和多器官功能障碍患者亚群的框架。其中一些方法仍处于研究的早期阶段,而另一些方法已在临床实践中常规使用,但这些方法将有助于在败血症中有效地产生和安全地实施精准医学。
{"title":"Precision medicine in sepsis and septic shock: From omics to clinical tools.","authors":"Juan Carlos Ruiz-Rodriguez, Erika P Plata-Menchaca, Luis Chiscano-Camón, Adolfo Ruiz-Sanmartin, Marcos Pérez-Carrasco, Clara Palmada, Vicent Ribas, Mónica Martínez-Gallo, Manuel Hernández-González, Juan J Gonzalez-Lopez, Nieves Larrosa, Ricard Ferrer","doi":"10.5492/wjccm.v11.i1.1","DOIUrl":"10.5492/wjccm.v11.i1.1","url":null,"abstract":"<p><p>Sepsis is a heterogeneous disease with variable clinical course and several clinical phenotypes. As it is associated with an increased risk of death, patients with this condition are candidates for receipt of a very well-structured and protocolized treatment. All patients should receive the fundamental pillars of sepsis management, which are infection control, initial resuscitation, and multiorgan support. However, specific subgroups of patients may benefit from a personalized approach with interventions targeted towards specific pathophysiological mechanisms. Herein, we will review the framework for identifying subpopulations of patients with sepsis, septic shock, and multiorgan dysfunction who may benefit from specific therapies. Some of these approaches are still in the early stages of research, while others are already in routine use in clinical practice, but together will help in the effective generation and safe implementation of precision medicine in sepsis.</p>","PeriodicalId":66959,"journal":{"name":"世界危重病急救学杂志(英文版)","volume":"11 1","pages":"1-21"},"PeriodicalIF":0.0,"publicationDate":"2022-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788206/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44659236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute exacerbation of interstitial lung disease in the intensive care unit. 重症监护室间质性肺疾病的急性加重
Pub Date : 2022-01-09 DOI: 10.5492/wjccm.v11.i1.22
Antonios Charokopos, Teng Moua, Jay H Ryu, Nathan J Smischney

Acute exacerbations of interstitial lung disease (AE-ILD) represent an acute, frequent and often highly morbid event in the disease course of ILD patients. Admission in the intensive care unit (ICU) is very common and the need for mechanical ventilation arises early. While non-invasive ventilation has shown promise in staving off intubation in selected patients, it is unclear whether mechanical ventilation can alter the exacerbation course unless it is a bridge to lung transplantation. Risk stratification using clinical and radiographic findings, and early palliative care involvement, are important in ICU care. In this review, we discuss many of the pathophysiological aspects of AE-ILD and raise the hypothesis that ventilation strategies used in acute respiratory distress syndrome might be implemented in AE-ILD. We present possible decision-making and management algorithms that can be used by the intensivist when caring for these patients.

间质性肺病(AE-ILD)的急性加重是ILD患者病程中的一种急性、频繁且往往高度病态的事件。进入重症监护室(ICU)是非常常见的,机械通气的需求很早就出现了。虽然无创通气在选定患者中显示出避免插管的前景,但尚不清楚机械通气是否能改变病情恶化的过程,除非它是肺移植的桥梁。使用临床和放射学检查结果进行风险分层,以及早期姑息治疗参与,在ICU护理中很重要。在这篇综述中,我们讨论了AE-ILD的许多病理生理方面,并提出了用于急性呼吸窘迫综合征的通气策略可能在AE-ILD中实施的假设。我们提出了可能的决策和管理算法,重症监护人员在照顾这些患者时可以使用这些算法。
{"title":"Acute exacerbation of interstitial lung disease in the intensive care unit.","authors":"Antonios Charokopos, Teng Moua, Jay H Ryu, Nathan J Smischney","doi":"10.5492/wjccm.v11.i1.22","DOIUrl":"10.5492/wjccm.v11.i1.22","url":null,"abstract":"<p><p>Acute exacerbations of interstitial lung disease (AE-ILD) represent an acute, frequent and often highly morbid event in the disease course of ILD patients. Admission in the intensive care unit (ICU) is very common and the need for mechanical ventilation arises early. While non-invasive ventilation has shown promise in staving off intubation in selected patients, it is unclear whether mechanical ventilation can alter the exacerbation course unless it is a bridge to lung transplantation. Risk stratification using clinical and radiographic findings, and early palliative care involvement, are important in ICU care. In this review, we discuss many of the pathophysiological aspects of AE-ILD and raise the hypothesis that ventilation strategies used in acute respiratory distress syndrome might be implemented in AE-ILD. We present possible decision-making and management algorithms that can be used by the intensivist when caring for these patients.</p>","PeriodicalId":66959,"journal":{"name":"世界危重病急救学杂志(英文版)","volume":"11 1","pages":"22-32"},"PeriodicalIF":0.0,"publicationDate":"2022-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788209/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46517438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
世界危重病急救学杂志(英文版)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1